May 13, 2020 4:40pm EDT DiaMedica Announces Positive Results in Top-Line Data from the Phase II ReMEDy Acute Ischemic Stroke Study and Provides a Business Update and First Quarter 2020 Financial Results
May 07, 2020 4:30pm EDT DiaMedica Therapeutics to Report First Quarter 2020 Financial Results and Provide a Business Update May 14, 2020
Mar 26, 2020 9:12am EDT DiaMedica Therapeutics to Present Research at National Kidney Foundation 2020 Spring Clinical Meetings Live Virtual Conference
Mar 23, 2020 4:35pm EDT DiaMedica Therapeutics Announces 2019 Financial Results and Provides Business Update
Mar 17, 2020 8:10am EDT DiaMedica Therapeutics to Report Fourth Quarter 2019 Financials and Provide a Business Update March 24, 2020
Mar 09, 2020 8:10am EDT DiaMedica Therapeutics to Participate at 32nd Annual ROTH Conference on March 15-17, 2020
Feb 13, 2020 4:35pm EST DiaMedica Therapeutics Announces Closing of $8.5 Million Public Offering of Common Shares
Dec 17, 2019 4:14pm EST DiaMedica Therapeutics Announces First Patient Dosed in REDUX Phase II Clinical Trial of DM199 for the Treatment of Chronic Kidney Disease
Nov 13, 2019 4:12pm EST DiaMedica Therapeutics Announces Third Quarter 2019 Financial Results and Provides Business Update
